Synthetic peptide corresponding to residues near the C-terminus of human LIM kinase 2.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab45165 in the following tested applications.
|IHC-P||Use at an assay dependent concentration.|
|ICC/IF||1/50 - 1/100.|
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
|WB||1/2000. Predicted molecular weight: 72 kDa.|